MediGain Services takes over MedBE
MedBE is involved in providing commercial services including revenue cycle management (RCM) and practice management to physicians throughout Louisiana and the Southeastern US. MedBE CEO Billy Chrysonthopolous said
The European Commission (EC) has approved an extended use of Johnson & Johnson’s Tecvayli (teclistamab), along with daratumumab, to treat adult patients with relapsed or refractory multiple myeloma (r/r MM).
Under the cooperative research and development agreement, Kite will develop engineered peripheral blood autologous T cell therapeutics (eACT), which contains proprietary tumor-specific T Cell Receptors (TCRs) and Chimeric